POA Pharma Scandinavia AB signs distribution agreements, with three new partners, in six countries for marketing and sale of products within the competence area of Medical Nutrition.
Tina Madsen Sandström, CEO for POA Pharma Scandinavia AB says:
“With the defined aim that before the end of 2014 have established presence in 16 countries outside the Nordics with our Metabolic range of products, we are pleased to announce the signing and introduction of our products in 6 new countries with 3 highly qualified partners.
The market for products defined as Food for specific Medical purposes or Medical Nutritiion is a very interesting and fast growing market all over the world and POA intends to be among the leading companies regarding these interesting areas.”
Novam-Nutriti LLC 15455 NW Greenbrier Parkway, Ste #100 Beaverton, OR 97006 for the sale and marketing of products for Inborn Error of Metabolism as well as for SPC Flakes and Salovum in USA and Canada. The products will be available from May.
David Lindsley, RDN, LD, CD // President of Novam-Nutriti makes the following statement:
”We have chosen to partner with the POA Group as we believes the POA Group provides better quality, innovation and science to support the efficacy of all products in their portfolio. We are looking forward to contributing in the design, manufacturing and distribution of future products.”
Metaboli Med s.r.o., with domicile in Prague and in Bratislava for the sale and marketing of products for Inborn Error of Metabolism in the Czech Republic and Slovakia. The products will be available from May.
Mrs Jana Simova, made the following statement:
"Metaboli Med s.r.o. was established in 2012. We are dedicated to providing quality formulas and medical foods for the treatment of rare metabolic disorders, especially PKU. POA Pharma Scandinavia AB is our exclusive supplier and we are proud exclusive representative in the Czech Republic and Slovak Republic lying in the middle of Europe. We believe that PKU supplements developed by POA Pharma Scandinavia give us great potential for further growth and success and what is more help our patients to live a better life.”
BioScenergy International Sdn Bhd (554775-K) with offices located in 19B, Jalan TK1/11A, Taman Kinrara 47180 Puchong, Selangor Malaysia. for the sale and marketing of SPC Flakes and Salovum in Malysia and Singapore of products for Inborn Error of Metabolism as well as for SPC Flakes and Salovum.
Mr K L Ang, Managing Director of BioScenergy International Sdn Bhd in Malaysia) has compiled the following statement:
”As a result of the partnership with POA Pharma “Scandinavia, BioScenergy International is very proud to be able to make available SPC-Flakes and Salovum in Malaysia and Singapore via its subsidiaries Pharm-D Malaysia and Pharm-D Singapore respectively. These innovative antisecretory factor products have a proven ability to provide meaningful relief to patients with inflammatory bowel disease (e.g. ulcerative colitits and Crohn's disease) and related problems such as short bowel syndrome and also to sufferers of Ménière's disease and mastitis”.